Montelukast to improve kidney and blood vessel function in type 1 diabetes
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether montelukast, a medicine commonly used for allergies, can improve kidney health and blood vessel function in adults with long-term type 1 diabetes. You may join a treatment group and have kidney and circulation measurements taken over the study period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 80
- You have type 1 diabetes for at least 5 years
- Your urine test shows albumin/creatinine ratio between 30 and 5000
- Your kidney filtration (eGFR) is between 30 and 89
- Your blood pressure is under 140/90 and stays on a stable plan
- You use stable insulin treatment (automated pump or multiple daily injections) for at least 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a daily medication can slow down kidney damage in people with type 1 diabetes who already have some kidney problems. It may help protect your kidneys from getting worse.
This trial tests a medication called finerenone to see if it can lower the amount of protein in your urine, which is a sign of kidney damage. It is for people with type 2 diabetes and chronic kidney disease who are already on standard blood pressure medications.
This study looks at whether a urine test can help doctors choose the right medicines earlier to prevent kidney and heart problems in people with type 2 diabetes. You may join if you have type 2 diabetes but no severe heart failure.
This trial tests whether a common asthma medication (montelukast) can help protect kidney, heart, and eye health in people with type 2 diabetes and early kidney problems. The study aims to see if the drug can slow down kidney damage and improve overall health.
This trial tests if montelukast, a common asthma medication, can help protect the kidneys and heart in adolescents and young adults with type 2 diabetes. It looks at how the drug affects markers of kidney function and blood vessel health over time.
This study tests new treatments for people with long-standing type 1 diabetes who also have early signs of heart or kidney disease. The goal is to see if these treatments can help protect the heart and kidneys.
Hear when a new Albuminuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.